This announcement is a separate document:
大参林：大参林医药集团股份有限公司公开发行可转换公司债券受托管理事务报告（2021年度）
Dashenlin: Report on the fiduciary management affairs of the public issuance of convertible corporate bonds by Dashenlin Pharmaceutical Group Co., Ltd. (2021)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.